Correspondence 0001715768-23-000025 from Transphorm, Inc. (CIK 0001715768)
Transphorm, Inc. (CIK 0001715768)
Date: April 27, 2023 · CIK: 0001715768 · Accession: 0001715768-23-000025
AI Filing Summary & Sentiment
File numbers found in text: 333-271380
Letter
Document
April 27, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Jenny O’Shanick
Re: Transphorm, Inc.
Registration Statement on Form S-3
File No. 333-271380
Filed on April 21, 2023
Acceleration Request
Requested Date: May 1, 2023
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Transphorm, Inc. hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-271380) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Erika Muhl at (650) 849-3352.
Sincerely,
TRANSPHORM, INC.
Show Raw Text
CORRESP 1 filename1.htm Document April 27, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Jenny O’Shanick Re: Transphorm, Inc. Registration Statement on Form S-3 File No. 333-271380 Filed on April 21, 2023 Acceleration Request Requested Date: May 1, 2023 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Transphorm, Inc. hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-271380) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Erika Muhl at (650) 849-3352. Sincerely, TRANSPHORM, INC. By: /s/ Cameron McAulay Cameron McAulay Chief Financial Officer cc: Erika Muhl, Wilson Sonsini Goodrich & Rosati